Clinical Trials
26 trialsBCB RIV
Institut du Cancer de Montpellier - Val d'Aurelle
STARTRK-2
Hoffmann-La Roche
TRIDENT-1
Turning Point Therapeutics, Inc.
iCaRe2
University of Nebraska
Lumed
University Hospital, Basel, Switzerland
ANTARES
Instituto do Cancer do Estado de São Paulo
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
FAPI PET RDRC
Jonsson Comprehensive Cancer Center
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Tanabe Pharma America, Inc.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
KEYNOTE 158
Merck Sharp & Dohme LLC
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Jonsson Comprehensive Cancer Center
CABATEN
Grupo Espanol de Tumores Neuroendocrinos
ARROW
Hoffmann-La Roche
Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors
Hutchmed
18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
Nanjing First Hospital, Nanjing Medical University
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
National Cancer Institute (NCI)
ROOT
Taproot Health
RaC-Ad
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
Universidad Nacional Autonoma de Mexico
ALpha-T
Hoffmann-La Roche
Cryoablation of Bone Metastases From Endocrine Tumors
Instituto do Cancer do Estado de São Paulo
PPGL-Pred
Rigshospitalet, Denmark
SELFIE
King's College London
B-Receptor Signaling in Cardiomyopathy
Stanford University
11C-Acetate PET/CT Non-FDG-Avid Tumors
Tel-Aviv Sourasky Medical Center